Skip to Content

Join the 'Diabetic Ketoacidosis (in DM Type II)' group to help and get support from people like you.

Diabetic Ketoacidosis (in DM Type II) News

A Better Diabetes Test?

Posted 5 Oct 2016 by Drugs.com

WEDNESDAY, Oct. 5, 2016 – Industry-funded researchers say they've developed a way to improve the accuracy of a standard diabetes test. "We think our approach will enable many patients and their doctors to do a better job controlling blood sugar levels and reduce the long-term risks of heart attack, stroke, blindness and kidney failure" associated with diabetes, said Dr. John Higgins, associate professor of systems biology at Harvard Medical School in Boston. At issue is the HbA1c test, also known as the A1c test, which is used to diagnose diabetes. It also identifies people with prediabetes and provides insight into how well blood sugar is controlled over a three-month period among those monitoring their disease. The A1c test "measures how much sugar a person's blood cells have soaked up since the time the cells were produced," Higgins said. "Before the test was available, patients and ... Read more

Related support groups: Diabetes, Type 2, Diabetes, Type 1, Diabetic Neuropathy, Insulin Resistance, Diabetic Nerve Damage, Pre-Diabetes, Diabetes Mellitus, Diabetic Ketoacidosis (DKA), Diabetic Retinopathy, Diagnosis and Investigation, Abnormal Glucose Tolerance, Diabetic Ketoacidosis (in DM Type II), Diabetic Ketoacidosis (in DM Type I), Diabetic Coma (in DM Type II), Retinopathy Prophylaxis, Diabetic Coma (in DM Type I), Diabetic Coma

Intensive Type 2 Diabetes Treatment Can Extend Survival: Study

Posted 8 Sep 2016 by Drugs.com

WEDNESDAY, Sept. 7, 2016 – Intensive management of type 2 diabetes can make a difference in how long and how well you live, even if you don't start until middle age, researchers report. People who were already at risk of type 2 diabetes complications were randomly selected to continue with their normal treatment or to be placed in an aggressive and multipronged treatment group. Two decades after the study began, the researchers found that people in the aggressive treatment group lived almost eight years longer. Not only that, they lived better – their risk of heart disease, kidney disease and blindness all dropped. The only complication that didn't seem to improve was nerve damage caused by diabetes. "Early, intensified intervention in type 2 diabetes patients with microalbuminuria with both target-driven pharmacological (medication) and behavioral actions increased life span. And, ... Read more

Related support groups: Diabetes, Type 2, Metformin, Insulin, Victoza, Lantus, Januvia, Glucophage, Novolog, Glipizide, Humalog, Janumet, Byetta, Glyburide, Saxenda, Bydureon, Lantus Solostar, Invokana, Levemir, Actos, Glimepiride

Nasal Spray May Give Diabetics Faster Treatment for Low Blood Sugar

Posted 18 Dec 2015 by Drugs.com

FRIDAY, Dec. 18, 2015 – A new nasal spray might make rescue care easier for diabetics who are woozy or even unconscious due to severe low blood sugar, a new clinical trial suggests. The nasal spray contains powdered glucagon, a hormone that causes a prompt increase in blood sugar levels. The trial results showed that the nasal spray is nearly as effective in treating hypoglycemia (low blood sugar) as the only option currently available, a glucagon powder that must be mixed with water, drawn into a syringe and then injected into muscle. Because it is almost as effective but much easier to administer to an ailing person, the nasal spray could become the go-to treatment for severe hypoglycemia, said Dr. George Grunberger, a clinical professor at Wayne State University School of Medicine in Detroit and president of the American Association of Clinical Endocrinologists. He was not involved ... Read more

Related support groups: Diabetes, Type 2, Diabetes, Type 1, Diabetic Neuropathy, Hypoglycemia, Insulin Resistance, Diabetic Nerve Damage, Pre-Diabetes, Diabetes Insipidus, Diabetes Mellitus, Diabetic Ketoacidosis (DKA), Diabetic Retinopathy, Abnormal Glucose Tolerance, Glucagon, Diabetic Ketoacidosis (in DM Type II), GlucaGen, Diabetic Ketoacidosis (in DM Type I), Diabetic Coma (in DM Type II), Intravenous Insulin Drip, Diabetic Coma (in DM Type I), Diabetic Coma

People with Type 2 Diabetes May Be Overtested

Posted 9 Dec 2015 by Drugs.com

TUESDAY, Dec. 8, 2015 – Many Americans with type 2 diabetes may be getting unnecessary blood sugar tests – and, in some cases, needless changes in medication, a new study suggests. Researchers found that in a large group of U.S. adults with well-controlled type 2 diabetes, 60 percent were undergoing too many hemoglobin A1C tests. The test, which gauges a person's average blood sugar control over the past three months, is routinely used to diagnose and monitor type 2 diabetes. But guidelines say it should be done only once or twice a year if a patient has been showing good blood sugar control, according to the study. All of the patients in the current study fell into that category. Yet nearly 55 percent underwent A1C tests three or four times per year. Another 6 percent had at least five tests per year, according to findings published online Dec. 8 in the journal BMJ. "I think part of ... Read more

Related support groups: Diabetes, Type 2, Insulin, Diagnosis and Investigation, Abnormal Glucose Tolerance, Diabetic Ketoacidosis (in DM Type II), Diabetic Coma (in DM Type II)

Tight Control of Type 2 Diabetes May Help Prevent Dementia

Posted 15 Sep 2015 by Drugs.com

TUESDAY, Sept. 15, 2015 – Keeping blood sugar levels in check may have a protective effect against dementia in people who have type 2 diabetes, new Swedish research suggests. "The positive association between [average blood sugar levels] and risk of dementia in fairly young patients with type 2 diabetes indicates a potential for prevention of dementia with improved blood sugar control," study author Dr. Aidin Rawshani, from the National Diabetes Register and Institute of Medicine in Gothenburg, Sweden, and colleagues wrote. However, the study wasn't able to definitively prove a cause-and-effect relationship between blood sugar levels and dementia; it was only able to show an association between these factors. The study included almost 350,000 people with type 2 diabetes. They were all registered in the Swedish National Diabetes Registry between January 2004 and December 2012. They had ... Read more

Related support groups: Diabetes, Type 2, Metformin, Insulin, Lantus, Dementia, Glucophage, Alzheimer's Disease, Novolog, Glipizide, Humalog, Janumet, Glyburide, Lantus Solostar, Invokana, Levemir, Actos, Glimepiride, Amaryl, Novolin R, Mild Cognitive Impairment

Health Tip: Diabetes Can Take a Toll on Teeth and Mouth

Posted 10 Aug 2015 by Drugs.com

-- Diabetes, especially when uncontrolled, can cause damage to your mouth and teeth. The Mouthhealthy.org website says possible effects of diabetes on the teeth and mouth include: Dry mouth, due to decreased saliva production. Increased risk of cavities due to less saliva. Gingivitis, characterized by bleeding, inflamed gums. Difficulty tasting food. Slower healing of mouth wounds. Increased risk of infection. Among diabetic children. teeth emerging earlier than expected. Read more

Related support groups: Diabetes, Type 2, Metformin, Insulin, Victoza, Oral and Dental Conditions, Xerostomia, Lantus, Toothache, Diabetes, Type 1, Januvia, Glucophage, Novolog, Burning Mouth Syndrome, Diabetic Neuropathy, Glipizide, Humalog, Insulin Resistance, Janumet, Diabetic Nerve Damage, Aphthous Ulcer

FDA Issues Warning for Type 2 Diabetes Drugs

Posted 18 May 2015 by Drugs.com

MONDAY, May 18, 2015 – A certain class of type 2 diabetes drugs can lead to a life-threatening condition called ketoacidosis, the U.S. Food and Drug Administration warns. These prescription drugs are called sodium-glucose cotransporter-2 (SGLT2) inhibitors and include canagliflozin, dapagliflozin and empagliflozin. They work by prompting the kidneys to remove sugar in the blood through urine. The drugs are sold under the brand names: Invokana (canagliflozin), Invokamet (canagliflozin and metformin), Farxiga (dapagliflozin), Xigduo XR (dapagliflozin and metformin extended-release), Jardiance (empagliflozin), Glyxambi (empagliflozin and linagliptin). Between March 2013 and June 2014, the FDA received 20 reports of the drugs triggering ketoacidosis, in which levels of blood acids called ketones are too high. If untreated, ketoacidosis can lead to a diabetic coma or even death, according ... Read more

Related support groups: Diabetes, Type 2, Invokana, Diabetes Mellitus, Farxiga, Jardiance, Diabetic Ketoacidosis (DKA), Glyxambi, Diabetic Ketoacidosis (in DM Type II), Canagliflozin, Invokamet, Dapagliflozin, Canagliflozin/metformin, Empagliflozin/linagliptin, Empagliflozin, Diabetic Coma (in DM Type II), Dapagliflozin/metformin

Ask a Question

Further Information

Related Condition Support Groups

Diabetes, Type 2